Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
Jefferies Downgrades Adagene(ADAG.US) to Hold Rating, Cuts Target Price to $3.5
Jefferies Downgrades Adagene to Hold From Buy, Price Target Is $3.50
10 trillion debt-for-equity swap, real estate tax policies will be introduced in the near future... One article to understand the NPC press conference
Starting from 2024, China will allocate 800 billion yuan from the annual increase in local government special bonds for five consecutive years, specifically for debt restructuring, with a cumulative potential to replace 4 trillion yuan in hidden debt. In addition, with the 6 trillion yuan debt ceiling approved by the National People's Congress Standing Committee this time, it will directly increase local debt resources by 10 trillion yuan.
Adagene | 6-K/A: Report of foreign private issuer (related to financial reporting)
Adagene Unveils Promising Data for Cancer Therapy
Adagene Unveils Data At SITC Highlighting Enhanced Therapeutic Index And Safety For Masked Anti-CTLA-4 SAFEbody ADG126, Showing Efficacy As Monotherapy And In Combination With Anti-PD-1 In Advanced MSS Colorectal Cancer
Adagene And 2 Other US Penny Stocks To Consider
Central Bank's major announcement! Reserve ratio cut, interest rate cut, officially launching share buyback and shareholding refinancing.
Pan Gongsheng stated that it is expected to carefully assess the market liquidity situation before the end of the year, and opportunistically further lower the deposit reserve ratio by 0.25-0.5 percentage points; reduce the open market 7-day reverse repurchase operation rate by 0.2 percentage points.
US stock market outlook: US September non-farm data higher than expected! Three major futures indicators surge in a straight line; will Chinese concept stocks continue to climb? Morgan Stanley: If short positions cover, it will push up the upward trend.
Bank of America: China stock fund saw the second highest inflow scale in history in the past week; European Central Bank Governing Council: inflation is under control, concerns arise as labor market cools down; spirit airlines plunged 33% before the market, the company is discussing potential bankruptcy application terms.
US stock market outlook: Three major futures indexes narrowed their pre-market declines, with most Chinese concept stocks weakening; Goldman Sachs is once again 'rooting' for the S&P! US stocks will see a big rise at the end of the year.
The Fed leads the way! The global rate cut pace is beginning to accelerate significantly; ongoing strikes at US ports lead to a sudden increase in inflation risks; Berkshire Hathaway plans to issue yen bonds for the second time this year, analysts say Buffett may be eyeing financial and shipping stocks.
Hong Kong and A-shares are in high spirits! How much room is left in the market under the new round of policies?
Interest rate-sensitive growth stocks, export chains driven by usa real estate demand, Hong Kong stocks local dividends and real estate, all show greater resilience in this round of rise.
Express News | The People's Bank of China: We need to speed up the introduction of financial increment policy measures files, and implement and implement each policy measure one by one.
Express News | The Central Financial Office and the China Securities Regulatory Commission jointly issued the "Guiding Opinions on Promoting the Entry of Medium to Long-term Funds into the Market".
Last night, Goldman Sachs' phone lines were jammed! Goldman Sachs answered the five most important questions from customers regarding the explosion of assets in China.
Goldman Sachs indicated that their buy volume in Hong Kong stocks and A-shares is 1.87 times, with buying mainly concentrated in Hong Kong.
HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $5 Price Target
Adagene Analyst Ratings
Buy Rating Affirmed on Adagene: Promising ADG126 Clinical Data and Market Underappreciation
Adagene's ADG126 Shows Promise in MSS CRC Therapy
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
No Data
No Data